Targeting a key enzyme in the microorganism responsible for the disease could stop both its growth and ability to infect ...

Researchers have discovered that an enzyme can serve as an ideal target for developing new therapeutics against Lyme disease, and most likely other tick-borne diseases as well.

Researchers have discovered that an enzyme can serve as an ideal target for developing new therapeutics against Lyme disease, ...

A team of scientists has zeroed in on an enzyme that could revolutionize Lyme disease treatment. By uncovering the crucial ...

Researchers at Virginia Commonwealth University discovered an enzyme, lactate dehydrogenase , as a potential therapeutic ...

The finding was reported in mBio, a journal of the American Society for Microbiology. Lyme disease is the most commonly reported tick-borne illness in the United States and Europe. Its causative ...

Researchers have discovered that an enzyme can serve as an ideal target for developing new therapeutics against Lyme disease, and ...

Lyme disease, the most common tick-borne illness in the U.S. and Europe, is caused by Borrelia burgdorferi. A new study may ...

Alpha-gal syndrome, a red meat allergy caused by a bite from the lone star tick, may also be triggered by the deer tick and the western black-legged tick.

Existing projects are also on hold because research institutions cannot be certain they will be continued, or if they absorb ...